TRXADE HEALTH INC (MEDS) Stock Earnings Estimates

USA Nasdaq NASDAQ:MEDS • US89846A4058

7.59 USD
+0.35 (+4.83%)
At close: Sep 20, 2024
7.591 USD
+0 (+0.01%)
After Hours: 9/20/2024, 8:07:08 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024
Revenue
YoY % growth
MEDS revenue by date.MEDS revenue by date.
9.89M
-42.23%
11.45M
15.77%
8.272M
-27.75%
9.486M
14.67%
EBITDA
YoY % growth
MEDS ebitda by date.MEDS ebitda by date.
-4.05M
-128.81%
-2.74M
32.35%
-6.429M
-134.64%
-663K
89.69%
EBIT
YoY % growth
MEDS ebit by date.MEDS ebit by date.
-4.06M
-128.09%
-2.75M
32.27%
-7.263M
-164.12%
-887.4K
87.78%
Operating Margin
MEDS operating margin by date.MEDS operating margin by date.
-41.05%-24.02%-87.80%-9.35%
EPS
YoY % growth
MEDS eps by date.MEDS eps by date.
-1.91
-730.43%
-4.80
-151.31%
N/A
77.69%
-0.46
57.14%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.150.00
100.00%
Revenue
Q2Q % growth
2.525M
22.69%
2.591M
10.14%
EBITDA
Q2Q % growth
-137.7K
73.04%
-40.8K
99.24%
EBIT
Q2Q % growth
-193.8K
77.07%
-96.9K
98.44%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth

94.72%
-0.15%
Q1 2024
Q2Q % growth

85.43%
-0.15%
Q4 2023
Q2Q % growth

-2.00%
-0.15%
Q3 2023
Q2Q % growth

83.00%
-0.15%
Q2 2023
Q2Q % growth
-2.90
-48.72%
-0.77-2.14-279.08%
Q1 2023
Q2Q % growth
-1.05
41.67%
-0.46-0.59-128.76%
Q4 2022
Q2Q % growth
-0.15
90.00%
-0.990.8484.92%
Q3 2022
Q2Q % growth
-0.90
-462.50%
-1.840.9450.98%
Q2 2022
Q2Q % growth
-1.95
-1,047.06%
-1.53-0.42-27.45%
Q1 2022
Q2Q % growth
-1.80
-2,150.00%
-1.73-0.07-3.81%
Q4 2021
Q2Q % growth
-1.50
-650.00%
-2.300.7934.64%
Q3 2021
Q2Q % growth
-0.16
-900.00%
-0.13-0.03-20.66%
Q2 2021
Q2Q % growth
-0.17
-142.86%
-0.09-0.08-92.30%
Q1 2021
Q2Q % growth
-0.08
-500.00%
-0.05-0.03-68.06%
Q4 2020
Q2Q % growth
-0.20 0.01-0.21-2,060.78%
Q3 2020
Q2Q % growth
0.02 0.03-0.01-34.64%
Q2 2020
Q2Q % growth
-0.07 0.01-0.08-786.27%
Q1 2020
Q2Q % growth
0.02 0.010.0196.08%
MEDS Yearly EPS VS EstimatesMEDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2020 2021 2022 2023 2024 0 -2 -4 -6 -8 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
18.7K
-99.17%
2.28M-2.261M-99.18%
Q1 2024
Q2Q % growth

-100.00%
2.091M-2.091M-100.00%
Q4 2023
Q2Q % growth
2.352M
-7.02%
2.392M-39.57K-1.65%
Q3 2023
Q2Q % growth
2.058M
-14.25%
2.326M-267.97K-11.52%
Q2 2023
Q2Q % growth
2.251M
-31.37%
2.101M150.08K7.14%
Q1 2023
Q2Q % growth
2.248M
-30.63%
2.716M-468.25K-17.24%
Q4 2022
Q2Q % growth
2.53M
5.86%
2.563M-33K-1.29%
Q3 2022
Q2Q % growth
2.4M
-5.88%
3.367M-967K-28.72%
Q2 2022
Q2Q % growth
3.28M
72.63%
2.989M291K9.74%
Q1 2022
Q2Q % growth
3.24M
6.23%
2.252M988K43.87%
Q4 2021
Q2Q % growth
2.39M
20.10%
2.122M268K12.63%
Q3 2021
Q2Q % growth
2.55M
-59.72%
2.029M521K25.68%
Q2 2021
Q2Q % growth
1.9M
-71.17%
2.321M-421K-18.14%
Q1 2021
Q2Q % growth
3.05M
38.64%
2.235M815K36.47%
Q4 2020
Q2Q % growth
1.99M 3.493M-1.503M-43.03%
Q3 2020
Q2Q % growth
6.33M 3.07M3.26M106.19%
Q2 2020
Q2Q % growth
6.59M 2.196M4.394M200.09%
MEDS Yearly Revenue VS EstimatesMEDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%